Our analysis revealed a mutation rate of 11.11% (6/54) in other cancer predisposition genes beyond BRCA1/2 in non-BRCA carriers, which was only slightly lower than that in the germline BRCA1/2 mutation carriers [14.19% (21/148)] in TNBC. The gene discussed is BRCA1; the disease is cancer.